For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

PGP87

4699N

Dr.Manikyam Anjali
Membership No Author Name Email Mobile
4699N Dr.Manikyam Anjali anjalianjumanikyam1999@gmail.com 8897718146
Medical Retina and Uvea

Structural and functional Response to Anti-Vascular Endothelial Growth Factor- Ranibizumab in patients with Diabetic Macular edema.

Purpose:To evaluate the predictive value of baseline Optical Coherence Tomography(OCT), Optical Coherence Tomography Angiography(OCTA) parameters and Best-corrected Visual Acuity(BCVA) to predict structural and functional response to anti-vascular endothelial growth factor therapy in Diabetic Macular Edema(DME).
Methods:This prospective observational study will include 54 eyes with DME. Baseline BCVA, OCT parameters(central macular thickness, disorganization of retinal inner layers, hyperreflective retinal foci, ellipsoid zone, external limiting membrane, subretinal fluid) and OCTA parameters(foveal avascular zone, vessel density and capillary non-perfusion) will be assessed before three monthly intravitreal anti-VEGF injections and correlated with post-treatment response.
Results:Participant recruitment and data collection are underway.
Conclusion:The ongoing study aims to identify OCT and OCTA parameters predictive of anti-VEGF response and support individualized management of DME.

Membership No Author Name Email Mobile
2377 Dr.Inchara Nagaraj dr.inchara@gmail.com 09000198625
3498 Dr.NARENDRAN BS narendranbs30@gmail.com 9686922767